9-133666782-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001134707.2(SARDH):c.2584G>A(p.Asp862Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000158 in 1,603,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001134707.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SARDH | NM_001134707.2 | c.2584G>A | p.Asp862Asn | missense_variant | 20/21 | ENST00000439388.6 | NP_001128179.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SARDH | ENST00000439388.6 | c.2584G>A | p.Asp862Asn | missense_variant | 20/21 | 2 | NM_001134707.2 | ENSP00000403084 | P1 | |
SARDH | ENST00000371872.8 | c.2584G>A | p.Asp862Asn | missense_variant | 20/21 | 1 | ENSP00000360938 | P1 | ||
SARDH | ENST00000371868.5 | c.934G>A | p.Asp312Asn | missense_variant | 8/9 | 2 | ENSP00000360934 | |||
SARDH | ENST00000469828.1 | n.342G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000284 AC: 65AN: 228914Hom.: 0 AF XY: 0.000250 AC XY: 31AN XY: 123864
GnomAD4 exome AF: 0.000152 AC: 220AN: 1450676Hom.: 0 Cov.: 32 AF XY: 0.000160 AC XY: 115AN XY: 720552
GnomAD4 genome AF: 0.000223 AC: 34AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74500
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at